Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Filgrastim × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 7 Leukemia, Biphenotypic, Acute 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Hodgkin Disease 4 Burkitt Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Osteosarcoma 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1

Interventions

pasireotide 1 E-7386 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡